News and Updates

Michael Abrahamson 8/14/23 Michael Abrahamson 8/14/23

Richard Austin To Present At Keiretsu Forum Panel On Transforming Therapy For Brain Diseases

Dr. Richard Austin will be presenting Reglagene at the Keiretsu Family Office Forum on August 16, 2023.

Michael Abrahamson 8/11/23 Michael Abrahamson 8/11/23

Reglagene's CEO Richard Austin is attending the 2023 SNO/ASCO CNS Cancer Conference.

Michael Abrahamson 6/7/23 Michael Abrahamson 6/7/23

At BIO2023, we presented our new preclinical efficacy data demonstrating Reglagene’s medicine outperforming the standard of care treatment.

Jorge Del Fabbro 4/14/23 Jorge Del Fabbro 4/14/23

Reglagene CEO Richard Austin leads off the Alumni session of Venture Madness 2023.

Jorge Del Fabbro 3/21/23 Jorge Del Fabbro 3/21/23

Thank you to Life Science Nation for selecting us to participate in the Innovator Pitch Challenge Oncology Therapeutics Vertical.

Jorge Del Fabbro 1/19/23 Jorge Del Fabbro 1/19/23

A very exciting presentation as Richard announced the selection of Reglagene's Clinical Candidate for brain cancer!

Jorge Del Fabbro 10/31/22 Jorge Del Fabbro 10/31/22

Reglagene's CEO Richard Austin presented on the main stage at Octane OC's Medical Innovation Forum.

Jorge Del Fabbro 10/26/22 Jorge Del Fabbro 10/26/22

Reglagene is headed to Orange County to participate in Octane's Medical Innovation Forum. Stop By our booth!

Jorge Del Fabbro 10/15/22 Jorge Del Fabbro 10/15/22

Reglagene is on the road again!